Roivant Sciences Ltd.insider trades

In SEC Form 4 filings, Roivant Sciences Ltd. is listed as Director, 10% owner of Arbutus Biopharma Corp ([ABUS]). Roivant Sciences Ltd. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 5.

Companies and roles

Company	Role	Transactions	Last filed
[ABUS]Arbutus Biopharma Corp	Director, 10% owner	1	Oct 5

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-05

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
[ABUS]Arbutus Biopharma Corp	Oct 1	Oct 5	D	8,967,383	$5.00	$44,836,915	29,880,079	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.